Healthcare Realty Trust (HR) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Achieved Q2 2025 Normalized FFO of $0.41 per share (up $0.02 sequentially), FAD of $0.33 per share, and reported a GAAP net loss of $(0.45) per share, reflecting significant impairments and lower rental income from dispositions.
Same-store occupancy reached 90% (up 40 bps sequentially), with same-store NOI growth of 5.1% year-over-year and robust leasing activity totaling 1.5 million sq ft.
Strategic overhaul underway, including a comprehensive plan focused on operational excellence, portfolio optimization, capital allocation, and leadership/board restructuring.
Dividend reduced by 23% to $0.24 per share quarterly, lowering payout ratio to ~80% and freeing $100 million annually for reinvestment.
Asset sales YTD total $211 million–$250 million completed, with $700 million–$900 million under contract or LOI, and a three-year growth framework targeting NFFO per share of $1.65–$1.85.
Financial highlights
Normalized FFO per share was $0.41 for Q2 2025, up from $0.38 year-over-year; FAD per share increased to $0.33, with a 96% payout ratio.
GAAP net loss attributable to common stockholders was $(157.9) million for Q2 2025, with rental income declining 6.8% year-over-year due to property dispositions.
Same-store cash NOI growth of 5.1% was the highest in nine years, with occupancy at 90% and margin reaching 64.3%.
Completed $211 million–$250 million in asset sales YTD at a blended 6.2% cap rate.
Quarterly dividend set at $0.24 per share, a 23% reduction, lowering the FAD payout ratio to ~80%.
Outlook and guidance
Raised full-year disposition outlook to $800 million–$1 billion, with $700 million–$900 million under contract or LOI.
Increased 2025 Normalized FFO per share guidance by $0.01 at the midpoint to $1.57–$1.61.
Projecting 75–125 bps of same-store occupancy absorption by year-end 2025 and 3.25%–4.00% same-store NOI growth.
Three-year Normalized FFO target set at $1.65–$1.85, driven by NOI growth, lease-up execution, and cost savings.
Management expects to fund 2025 dividends from operations and available liquidity.
Latest events from Healthcare Realty Trust
- Strong leasing, $1.2B asset sales, and improved leverage drive positive 2025 and 2026 outlook.HR
Q4 202513 Feb 2026 - Q2 net loss on impairments, but strong leasing, asset sales, and FFO guidance affirmed.HR
Q2 20242 Feb 2026 - Normalized FFO per share rose 1.2% as leasing, asset sales, and share buybacks drove activity.HR
Q3 202417 Jan 2026 - Record leasing, robust FFO growth, and deleveraging highlight 2024 performance.HR
Q4 202429 Dec 2025 - Normalized FFO per share was $0.39 in Q1 2025, with improved net loss and strong leasing.HR
Q1 202527 Dec 2025 - Board recommends approval of all proposals, with strong focus on pay-for-performance and ESG.HR
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.HR
Proxy Filing1 Dec 2025 - Q3 2025 saw 5% FFO growth, strong leasing, asset sales, and improved guidance despite a net loss.HR
Q3 20252 Nov 2025